Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Richard A. Lewis, M.D., has been appointed as chair of Aerie’s Scientific Advisory Board, replacing David L. Epstein, M.D. Dr. Lewis’ appointment at Aerie is effective immediately.
Help employers find you! Check out all the jobs and post your resume.
